USP7部分通过PU.1稳定维持造血干细胞稳定
Huizhuang Shan1,2, Youping Zhang1, Xinhua Xiao3
1Institute for Translational Medicine on Cell Fate and Disease, Shanghai Ninth People's Hospital, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
International journal of biological sciences
|January 12, 2026
概括
乌比基特异性蛋白酶7 (USP7) 对于维持造血干细胞 (HSC) 至关重要. 失去USP7会破坏转录因子PU.1的稳定,导致造血失败和潜在的治疗点.
科学领域:
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
- 分子生物学分子生物学
背景情况:
- 翻译后的修改调节了造血干细胞 (HSC) 的功能.
- 在HSC的维护和血统承诺中,duebiquitination的作用在很大程度上是未知的.
研究的目的:
- 调查泛素特异蛋白酶7 (USP7) 在HSC维护和造血平衡中的作用.
- 阐明USP7调节HSC命运的分子机制.
主要方法:
- 在小鼠HSC中条件删除Usp7基因.
- 分析HSC功能的分析,包括静止,再生能力和血统差异化.
- 生物化学测试以确定USP7-PU.1相互作用及其对PU.1稳定性的影响.
- 竞争性移植测试以评估HSC的自我更新和移植.
主要成果:
- 在HSC中有条件的Usp7删除导致了快速的干细胞枯竭,多系细胞衰竭和造血失败.
- 缺乏Usp7的HSC显示出有缺陷的静止状态,减少了再生能力和异常分化.
- USP7直接对转录因子PU.1进行二基化和稳定,保护其免受蛋白质体降解.
- 丢失USP7破坏了PU.1的稳定性,抑制了HSC静止和谱系规范的关键目标基因.
- USP7-null HSC 在竞争性移植中表现出严重受损的自我更新和差异化.
- 宫外PU.1表达在没有USP7.7.的情况下部分挽救了HSC功能.
结论:
- USP7是维持HSC和造血平衡的关键调节者.
- USP7-PU.1 轴代表了一种新的,依赖于二氧化的机制,可以控制高细胞的命运.
- 针对USP7-PU.1相互作用可能为造血性疾病提供治疗策略.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Hematopoiesis
8.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K
Maintenance of the ES Cell State
2.7K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.7K


